Hydroxychloroquine does not benefit adults hospitalized with COVID-19

The trial began after lab studies and preliminary reports suggested that hydroxychloroquine might have promise in treating SARS-CoV-2.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news